Ferček Iva, Lugović-Mihić Liborija, Tambić-Andrašević Arjana, Ćesić Diana, Grginić Ana Gverić, Bešlić Iva, Mravak-Stipetić Marinka, Mihatov-Štefanović Iva, Buntić Ana-Marija, Čivljak Rok
Department of Dermatovenereology, Sestre Milosrdnice University Hospital Center, 10000 Zagreb, Croatia.
Department of Ophthalmology, Sestre Milosrdnice University Hospital Center, 10000 Zagreb, Croatia.
Life (Basel). 2021 Sep 14;11(9):962. doi: 10.3390/life11090962.
Many relatively common chronic inflammatory skin diseases manifest on the face (seborrheic dermatitis, rosacea, acne, perioral/periorificial dermatitis, periocular dermatitis, etc.), thereby significantly impairing patient appearance and quality of life. Given the yet unexplained pathogenesis and numerous factors involved, these diseases often present therapeutic challenges. The term "microbiome" comprises the totality of microorganisms (microbiota), their genomes, and environmental factors in a particular environment. Changes in human skin microbiota composition and/or functionality are believed to trigger immune dysregulation, and consequently an inflammatory response, thereby playing a potentially significant role in the clinical manifestations and treatment of these diseases. Although cultivation methods have traditionally been used in studies of bacterial microbiome species, a large number of bacterial strains cannot be grown in the laboratory. Since standard culture-dependent methods detect fewer than 1% of all bacterial species, a metagenomic approach could be used to detect bacteria that cannot be cultivated. The skin microbiome exhibits spatial distribution associated with the microenvironment (sebaceous, moist, and dry areas). However, although disturbance of the skin microbiome can lead to a number of pathological conditions and diseases, it is still not clear whether skin diseases result from change in the microbiome or cause such a change. Thus far, the skin microbiome has been studied in atopic dermatitis, seborrheic dermatitis, psoriasis, acne, and rosacea. Studies on the possible association between changes in the microbiome and their association with skin diseases have improved the understanding of disease development, diagnostics, and therapeutics. The identification of the bacterial markers associated with particular inflammatory skin diseases would significantly accelerate the diagnostics and reduce treatment costs. Microbiota research and determination could facilitate the identification of potential causes of skin diseases that cannot be detected by simpler methods, thereby contributing to the design and development of more effective therapies.
许多相对常见的慢性炎症性皮肤病会表现在面部(脂溢性皮炎、酒渣鼻、痤疮、口周/口周皮炎、眼周皮炎等),从而显著损害患者的外貌和生活质量。鉴于其发病机制尚未明确且涉及众多因素,这些疾病往往带来治疗挑战。“微生物群”一词包括特定环境中微生物(微生物群落)的总体、它们的基因组以及环境因素。人们认为人类皮肤微生物群组成和/或功能的变化会引发免疫失调,进而引发炎症反应,从而在这些疾病的临床表现和治疗中发挥潜在的重要作用。尽管传统上培养方法一直用于细菌微生物群落物种的研究,但大量细菌菌株无法在实验室中培养。由于依赖标准培养的方法检测到的所有细菌物种不到1%,因此可以使用宏基因组方法来检测无法培养的细菌。皮肤微生物群呈现出与微环境(皮脂腺、湿润和干燥区域)相关的空间分布。然而,尽管皮肤微生物群的紊乱会导致多种病理状况和疾病,但仍不清楚皮肤病是由微生物群的变化引起的还是导致了这种变化。到目前为止,已经在特应性皮炎、脂溢性皮炎、银屑病、痤疮和酒渣鼻等疾病中对皮肤微生物群进行了研究。关于微生物群变化与皮肤病之间可能存在的关联的研究,增进了人们对疾病发展、诊断和治疗的理解。识别与特定炎症性皮肤病相关的细菌标志物将显著加快诊断速度并降低治疗成本。微生物群落研究和测定有助于识别用更简单方法无法检测到的皮肤病潜在病因,从而有助于设计和开发更有效的治疗方法。